Financials

  • Market Capitalization 307.43 M
  • Employee 117
  • Founded 1999
  • CEO N/A
  • Website www.niagenbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG000BG1J71
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
31.8
ratio cours/chiffre d'affaires
4.2

Niagen Bioscience, Inc. - Common Stock

Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ.